By Denise DeWitt A new product just approved by the U.S. Food and Drug Administration is offering new hope to elderly patients with end-stage age-related macular degeneration (AMD). The implantable, miniature telescope is considered breakthrough technology to help offset the effects of AMD, which results in functional vision loss and is the leading cause of […]
Allergan Inc. said today, June 18th, 2009, that the Food and Drug Administration approved a drug it developed to treat macular edema, a condition that can cause loss of central vision. Irvine-based Allergan says the drug, trade-named Ozurdex, is the first and only drug therapy approved for treating macular edema associated with retinal vein occlusion, the […]